• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疫苗研发。

Vaccine Development.

机构信息

Center for Vaccine Development and Global Health, University of Maryland School of Medicine, 685 West Baltimore Street, Room 480, Baltimore, MD 21201, USA; Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD, USA.

Center for Vaccine Development and Global Health, University of Maryland School of Medicine, 685 West Baltimore Street, Room 480, Baltimore, MD 21201, USA; Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD, USA.

出版信息

Pediatr Clin North Am. 2024 Jun;71(3):529-549. doi: 10.1016/j.pcl.2024.01.018. Epub 2024 Mar 12.

DOI:10.1016/j.pcl.2024.01.018
PMID:38754940
Abstract

This article considers ethical considerations surrounding pediatric vaccine development for pandemic preparedness, examines some historical cases of pediatric vaccines developed during past smallpox, influenza, and 2019 coronavirus disease pandemics, and discusses the current state of vaccine development for pandemic preparedness, including vaccines against smallpox/mpox, influenza, anthrax, and Ebola that are included in the US Strategic National Stockpile and vaccines being developed against priority pathogens identified by the World Health Organization.

摘要

本文考虑了围绕儿科疫苗研发以应对大流行所涉及的伦理问题,考察了过去天花、流感和 2019 年冠状病毒病大流行期间研发儿科疫苗的一些历史案例,并讨论了当前大流行准备疫苗研发的现状,包括纳入美国战略国家储备的天花/猴痘、流感、炭疽和埃博拉疫苗,以及正在针对世界卫生组织确定的优先病原体开发的疫苗。

相似文献

1
Vaccine Development.疫苗研发。
Pediatr Clin North Am. 2024 Jun;71(3):529-549. doi: 10.1016/j.pcl.2024.01.018. Epub 2024 Mar 12.
2
Mpox: emergence following smallpox eradication, ongoing outbreaks and strategies for prevention.猴痘:天花根除后的出现、持续爆发及预防策略
Curr Opin Infect Dis. 2025 Jun 1;38(3):222-227. doi: 10.1097/QCO.0000000000001100. Epub 2025 Jan 29.
3
Africa aims to avert an mpox pandemic.非洲旨在避免猴痘大流行。
Science. 2024 Oct 4;386(6717):7. doi: 10.1126/science.adt4793. Epub 2024 Oct 3.
4
Effectiveness of historical smallpox vaccination against mpox clade II in men in Denmark, France, the Netherlands and Spain, 2022.2022 年丹麦、法国、荷兰和西班牙男性中历史小痘接种对 mpox Ⅱ型分支的有效性。
Euro Surveill. 2024 Aug;29(34). doi: 10.2807/1560-7917.ES.2024.29.34.2400139.
5
Human monkeypox virus in the shadow of the COVID-19 pandemic.人类猴痘病毒在 COVID-19 大流行的阴影下。
J Infect Public Health. 2023 Aug;16(8):1149-1157. doi: 10.1016/j.jiph.2023.05.013. Epub 2023 May 13.
6
Progress and prospects on vaccine development against monkeypox infection.针对猴痘感染的疫苗研发进展与前景。
Microb Pathog. 2023 Jul;180:106156. doi: 10.1016/j.micpath.2023.106156. Epub 2023 May 16.
7
Global perspectives on smallpox vaccine against monkeypox: a comprehensive meta-analysis and systematic review of effectiveness, protection, safety and cross-immunogenicity.全球视角下的天花疫苗对猴痘的效果、保护作用、安全性和交叉免疫原性:一项综合的荟萃分析和系统评价。
Emerg Microbes Infect. 2024 Dec;13(1):2387442. doi: 10.1080/22221751.2024.2387442. Epub 2024 Aug 16.
8
Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for the Re-Emerging Human Monkeypox Virus.人猴痘病毒再现的流行病学、诊断、治疗和疫苗现状。
J Microbiol Biotechnol. 2023 Aug 28;33(8):981-991. doi: 10.4014/jmb.2306.06033. Epub 2023 Jul 25.
9
Mpox: Global epidemic situation and countermeasures.猴痘:全球疫情形势与应对措施。
Virulence. 2025 Dec;16(1):2457958. doi: 10.1080/21505594.2025.2457958. Epub 2025 Feb 8.
10
Update on Mpox Management: Epidemiology, Vaccines and Therapeutics, and Regulatory Changes.猴痘管理最新情况:流行病学、疫苗与治疗方法以及监管变化
Drugs. 2025 Jan;85(1):1-9. doi: 10.1007/s40265-024-02117-1. Epub 2024 Nov 5.

引用本文的文献

1
Harnessing mRNA for heart health: a new era in cardiovascular treatment.利用信使核糖核酸促进心脏健康:心血管治疗的新时代。
Theranostics. 2025 Jul 2;15(15):7779-7801. doi: 10.7150/thno.111503. eCollection 2025.
2
Production and Immune Response Against Pandemic Influenza Candidate Vaccines as Preparedness Against the Circulating H5N1 Influenza Viruses.针对大流行性流感候选疫苗的生产及免疫反应,作为应对正在传播的H5N1流感病毒的防范措施。
Vaccines (Basel). 2025 Jun 8;13(6):620. doi: 10.3390/vaccines13060620.
3
Evaluating Nanoparticulate Vaccine Formulations for Effective Antigen Presentation and T-Cell Proliferation Using an In Vitro Overlay Assay.
使用体外覆盖分析评估纳米颗粒疫苗制剂的有效抗原呈递和T细胞增殖情况。
Vaccines (Basel). 2024 Sep 13;12(9):1049. doi: 10.3390/vaccines12091049.